Clinical Trials on Neoplasms, Neuroepithelial

Total 107167 results

Eisai Co., Ltd.

Completed

Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma

Malignant Glioma

Japan
Maastricht Radiation Oncology
The Limburg University Fund

Terminated

Spatial Analysis and Validation of Glioblastoma on 7 T MRI

Glioblastoma

Netherlands
Actelion

Terminated

Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma

Glioblastoma

United States
University of Pisa
Azienda Ospedaliero, Universitaria Pisana

Completed

Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy (GLIOMELA)

Glioblastoma

Italy
Massachusetts General Hospital

Completed

MET-PET for Newly Diagnosed Glioblastoma

Glioblastoma

United States
Rigshospitalet, Denmark

Terminated

Image-derived Prediction of Response to Chemo-radiation in Glioblastoma (IDEPREG)

Glioblastoma

Denmark
Hoffmann-La Roche

Completed

A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

Glioblastoma

United States, United Kingdom, Belgium, Denmark, Korea, Republic of, Poland, Spain, Canada, Sweden, Russian Federation, Australia, Greece, Portugal, France, Netherlands, New Zealand, Switzerland, Germany, Hong Kong, Hungary, Israel and more
Merck Sharp & Dohme LLC

Completed

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Glioblastoma
Merck Sharp & Dohme LLC

Completed

Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)

Glioblastoma
Cedars-Sinai Medical Center

Completed

Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma

Malignant Glioma

United States
EMD Serono
Merck KGaA, Darmstadt, Germany

Completed

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status (CORE)

Glioblastoma

United States, Germany
Hospices Civils de Lyon

Unknown

MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS (RESECT)

Glioblastoma

France
Assistance Publique Hopitaux De Marseille

Unknown

Cerebral Bases Bodily Representations (EBA)

Glial Tumors

France
Center Eugene Marquis
Rennes University Hospital

Completed

Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients (ECOM)

Glioblastoma

France
Tampa General Hospital

Completed

Preoperative Chemoradiation for Glioblastoma

Glioblastoma

United States
Merck Sharp & Dohme LLC

Completed

Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)

Glioblastoma
Merck Sharp & Dohme LLC

Completed

Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)

Glioma | Glioblastoma | Astrocytoma
EMD Serono
Merck KGaA, Darmstadt, Germany; European Organisation for Research and Treatment...

Completed

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status (CENTRIC)

Glioblastoma

United States, Germany
Rutgers, The State University of New Jersey
Rutgers Cancer Institute of New Jersey

Terminated

MRI-Guided Laser Induced Thermal Therapy (LITT)

Malignant Glioma

United States
Genentech, Inc.

Completed

A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)

Glioblastoma
Hoffmann-La Roche
Pediatric Brain Tumor Consortium

Completed

A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas

Brainstem Glioma

United States
Washington University School of Medicine
Barnes-Jewish Hospital

Completed

Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma

Glioblastoma

United States
Cedars-Sinai Medical Center

Completed

Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients (Gliadel Wafer)

Malignant Glioma

United States
GC Cell Corporation

Completed

Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

Glioblastoma

Korea, Republic of
Centre Georges Francois Leclerc
Ligue contre le cancer, France

Completed

Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults (SIB-IMRT)

Glioblastoma

France
Nobelpharma

Completed

Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas

Malignant Glioma

Japan
Massachusetts General Hospital
Dana-Farber Cancer Institute

Terminated

Evaluating Tumor Pseudoprogression With FLT-PET and MRI

Glioblastoma

United States
University of Regensburg
Essex Pharma Germany

Completed

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma

Germany
Pfizer

Completed

Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme

Glioblastoma

South Africa, Italy, Russian Federation, United States, Canada, Germany, Australia, Austria, Croatia, Czech Republic, France, India, Spain
Institut Claudius Regaud
NovoCure Ltd.

Not yet recruiting

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma (EXOFIELDS)

Glioblastoma

France
Erasmus Medical Center

Recruiting

Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma (MOSAIC)

Glioblastoma

Netherlands
Charlotte Lemech
The University of New South Wales

Not yet recruiting

Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma

Glioblastoma
Rznomics, Inc.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Glioblastoma
Ludwig-Maximilians - University of Munich

Recruiting

Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma (PRIDE)

Glioblastoma

Germany
Kepler University Hospital

Recruiting

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

Glioblastoma

Austria
Power Life Sciences Inc.

Not yet recruiting

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Glioblastoma
Peter Siesjö
Lund University

Recruiting

Antisecretory Factor Glioblastoma Phase 2 (AFGB2)

Glioblastoma

Sweden
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Not yet recruiting

Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?

Glioblastoma
Institut de cancérologie Strasbourg Europe
Centre Georges Francois Leclerc

Not yet recruiting

Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study (ReciDOPA)

Glioblastoma

France
Cantex Pharmaceuticals

Recruiting

Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma

Spain
Istituto Clinico Humanitas

Recruiting

Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity (GEHIRN)

Glioblastoma

Italy
Karolinska University Hospital
Celluminova AB

Recruiting

Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem (CeNo2)

Glioma, Malignant

Sweden
Henan Provincial People's Hospital

Not yet recruiting

Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers

Glioblastoma

China
Seoul National University Boramae Hospital

Not yet recruiting

Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

Glioblastoma
Clinical Laserthermia Systems AB

Recruiting

Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions

Glioblastoma

Sweden
King's College Hospital NHS Trust
King's College London

Not yet recruiting

Establishing Radiolabelled PSMA as a Target for Glioma Treatment

Glioma, Malignant

United Kingdom
Sun Yat-sen University

Recruiting

Newly Diagnosed Glioblastoma

Glioblastoma

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma

Glioblastoma

China
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...

Recruiting

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme (DENDR1)

Glioblastoma

Italy
NovoCure Ltd.

Recruiting

TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study

Glioblastoma

Germany

3

Subscribe